What drove MLBON.PA stock higher on 29 Jan 2026?

The 21.21% rise to €4.80 occurred on extremely low volume (2 shares). There was no earnings release; the move appears driven by isolated trades rather than broad news or consensus upgrades.

How does bonyf’s valuation compare with its healthcare peers?

bonyf shows a negative EPS and PE, while the healthcare sector average PE is about 34.44. bonyf’s PB is **1.07**, below many peers, but thin revenues and high price-to-sales **10.04** make comparisons imperfect.

What is the Meyka AI forecast for MLBON.PA stock?

Meyka AI's model projects a monthly level of **€5.50** and a yearly level of **€4.87** versus the current **€4.80**. These are model projections and not guarantees; liquidity and fundamental news will drive real outcomes.

Should I trade MLBON.PA on this move?

Trading is possible for short-term momentum but carries high execution risk due to low volume and wide spreads. Limit orders and strict risk controls are essential; consider small position sizes until liquidity improves.

EU Stocks

bonyf N.V. (MLBON.PA EURONEXT) up 21.21% to €4.80 on 29 Jan 2026: liquidity and outlook

ByDanny Kontos January 29, 2026January 29, 2026

bonyf N.V. (MLBON.PA) jumped 21.21% to €4.80 on 29 Jan 2026, making it one of today’s largest percentage movers on EURONEXT. MLBON.PA stock rose from a previous close of €3.96 with only 2 shares reported traded, underlining a sharp price swing on very low liquidity. The move follows no public earnings release, so traders are weighing short-term technicals against thin market depth and stretched valuation metrics.